SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-19-001662
Filing Date
2019-08-02
Accepted
2019-08-02 16:41:45
Documents
6
Period of Report
2019-08-02

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tv526596_6k.htm 6-K 13167
2 EXHIBIT 99.1 tv526596_ex99-1.htm EX-99.1 19176
3 EXHIBIT 99.2 tv526596_ex99-2.htm EX-99.2 17690
4 EXHIBIT 99.3 tv526596_ex99-3.htm EX-99.3 275323
5 GRAPHIC image_001.jpg GRAPHIC 3613
6 GRAPHIC image_002.jpg GRAPHIC 3644
  Complete submission text file 0001279569-19-001662.txt   336850
Mailing Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7
Business Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7 1-604-677-6905
Correvio Pharma Corp. (Filer) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-29338 | Film No.: 19996532
SIC: 2834 Pharmaceutical Preparations